Abstract
This chapter deals with the intricate ethical landscape surrounding the development of nanocarriers for treating neurodegenerative diseases. Critical challenges and ethical considerations emerge as researchers explore novel therapeutic avenues at the nanoscopic level. The discussion encompasses safety and toxicity concerns, emphasizing the importance of ensuring the well-being of patients involved in these ground-breaking studies. The chapter scrutinizes the nuanced issues surrounding informed consent, recognizing the unique nature of interventions at the nanoscale. Informed consent processes must adapt to the intricacies of these advanced technologies, ensuring that participants comprehend the potential risks and benefits associated with nanocarrier-based treatments. Furthermore, the text explores the imperative of establishing robust regulatory frameworks to guide the ethical development of nanocarriers. Given the pioneering nature of these interventions, regulatory bodies play a crucial role in safeguarding both the scientific integrity and ethical principles governing research and clinical applications. Throughout the chapter, the reader is invited to contemplate the ethical dimensions of pursuing innovative solutions for neurodegenerative diseases. Balancing scientific progress with ethical imperatives, this exploration encourages a thoughtful and responsible approach to nanocarrier development, fostering a deeper understanding of the ethical considerations that shape the future of neurodegenerative disease therapeutics.
| Original language | English |
|---|---|
| Title of host publication | The Neurodegeneration Revolution |
| Subtitle of host publication | Emerging Therapies and Sustainable Solutions |
| Publisher | Elsevier |
| Pages | 399-420 |
| Number of pages | 22 |
| ISBN (Electronic) | 9780443288227 |
| ISBN (Print) | 9780443288234 |
| DOIs | |
| Publication status | Published - 01-01-2024 |
All Science Journal Classification (ASJC) codes
- General Psychology